Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder.

Ítems similars

• Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.
  per: Molto, L., et al.
  Publicat: (1994)
• The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients
  per: Reyes, E, et al.
  Publicat: (1999)
• Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer
  per: PAGÈS, F, et al.
  Publicat: (2002)
• INTERFERON ALPHA TREATMENT OF PATIENTS WITH IMPAIRED INTERFERON GAMMA SIGNALING
  per: Bax, HI, et al.
  Publicat: (2013)
• Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells
  Publicat: (1989)